Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: AZD8233
Study Purpose: This study was done to learn how well different doses of AZD8233 work in people with high levels of low-density lipoprotein cholesterol, also called LDL cholesterol
Protocol Number: D7990C00003
Thank you!
Thank you to the participants who took part in the clinical study for the study drug AZD8233.
All of the participants helped researchers learn more about different doses of AZD8233 to help people with high levels of a type of cholesterol known as "low-density lipoprotein cholesterol", also called LDL cholesterol or "bad" cholesterol.
AstraZeneca sponsored this study and believes it is important to share the results of the study with you and the public. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you. We hope it helps you understand and feel proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.